Merdury Biopharmaceutical Corporation (TPEX:6932)
8.65
-0.24 (-2.70%)
Mar 2, 2026, 2:01 PM CST
-46.93% (1Y)
| Market Cap | 3.72B |
| Revenue (ttm) | 246.00K |
| Net Income (ttm) | -70.59M |
| Shares Out | 418.44M |
| EPS (ttm) | -0.17 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 1,000 |
| Average Volume | 914,370 |
| Open | 8.80 |
| Previous Close | 8.89 |
| Day's Range | 8.51 - 8.85 |
| 52-Week Range | 4.95 - 17.45 |
| Beta | -2.63 |
| RSI | 50.21 |
| Earnings Date | Apr 2, 2026 |